Neuphoria Therapeutics Inc.
NEUP
Rangering i aksjer
#29248
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Aksjekurs
$3.92
Sist synkronisert: 2026-07-31
Markedsverdi
$21.16M
Endring (1 dag)
-0.13%
Endring (1 år)
60,767.52%
Land
US
Handel Neuphoria Therapeutics Inc. (NEUP)
Kategori
Healthcare
Historikk for aksjesplitt for Neuphoria Therapeutics Inc. (NEUP)
Aksjen Neuphoria Therapeutics Inc. (symbol: NEUP) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én NEUP-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 NEUP-aksjer.
Den nyeste splittelsen skjedde Oct 21, 2026.
Én NEUP-aksje kjøpt før Oct 21, 2026 tilsvarer i dag 0 NEUP-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
